Acadia Healthcare (ACHC) Set to Announce Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) is scheduled to be releasing its earnings data after the market closes on Wednesday, May 1st. Analysts expect Acadia Healthcare to post earnings of $0.80 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million during the quarter, compared to analysts’ expectations of $727.60 million. During the same period in the prior year, the firm posted $0.70 earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. On average, analysts expect Acadia Healthcare to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Acadia Healthcare Trading Up 1.4 %

Shares of Acadia Healthcare stock opened at $74.61 on Tuesday. The stock has a market cap of $6.90 billion, a P/E ratio of -298.43, a P/E/G ratio of 2.17 and a beta of 1.31. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 12-month low of $66.49 and a 12-month high of $87.77. The business’s 50 day moving average is $77.91 and its 200-day moving average is $77.73.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Barclays initiated coverage on shares of Acadia Healthcare in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 target price for the company. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a report on Thursday, April 25th. TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. TD Cowen upped their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $92.00.

Insider Activity at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.